Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Glenn J Hanna
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Keck Medicine of Usc Koreatown
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Usc Norris Oncology/hematology-Newport Beach
Newport Beach, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, United States
- Northshore University Healthsystem-Glenbrook Hospital
Glenview, Illinois, United States
- Northwestern Medicine Glenview Outpatient Center
Glenview, Illinois, United States
- Northwestern Medicine Grayslake Outpatient Center
Grayslake, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Northshore University Healthsystem-Highland Park Hospital
Highland Park, Illinois, United States
- Northwestern Medicine Lake Forest Hospital
Lake Forest, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- Northwestern Medicine Orland Park
Orland Park, Illinois, United States
- University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, United States
- Ui Health Care Mission Cancer and Blood - Ankeny Clinic
Ankeny, Iowa, United States
- Mercy Cancer Center-West Lakes
Clive, Iowa, United States
- Ui Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive, Iowa, United States
- Heartland Oncology and Hematology Llp
Council Bluffs, Iowa, United States
- Methodist Jennie Edmundson Hospital
Council Bluffs, Iowa, United States
- Nebraska Cancer Specialists/oncology Hematology West Pc - Mej
Council Bluffs, Iowa, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Feb 2024
- Primary completion
- 16 Jun 2028
- Completion
- 16 Jun 2028
- Last update posted
- 15 Jun 2026
- Registered enrollment
- 50
- Registry id
- NCT05904080
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.